← Back to Search

Dexmedetomidine vs Propofol Sedation for Pediatric Obstructive Sleep Apnea

Phase 2
Recruiting
Led By Erin Kirkham, MD MPH
Research Sponsored by Erin Kirkham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Considered to be a surgical candidate for adenotonsillectomy to treat OSA by a board-certified or board-eligible otolaryngologist.
Diagnosed with Obstructive sleep apnea (OSA) by the following criteria: Obstructive Apnea Index (OAI) ≥ 1 or Apnea Hypopnea Index (AHI) ≥ 1.5, confirmed on nocturnal, laboratory-based polysomnography within the previous 6 months scored using American Academy of Sleep Medicine pediatric criteria in an accredited sleep lab.
Must not have
History of allergic reaction to or contraindication to receiving propofol, dexmedetomidine, ketamine or sevoflurane
Contraindication to receiving general anesthesia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during drug induced sleep endoscopy (dise) procedure, as judged subsequently by video review by the three raters
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effects of two anesthetics on upper airway collapse during sleep endoscopy in children with sleep apnea.

Who is the study for?
This trial is for children aged 3 to under 12 with obstructive sleep apnea confirmed by a sleep study. They should benefit from a sleep endoscopy before tonsil and adenoid removal surgery, especially if they are obese, have severe OSA, small tonsils but severe symptoms, are African American or over 7 years old. Kids who've had previous upper airway surgeries or have certain medical risks or allergies can't participate.
What is being tested?
The study compares the effects of two sedatives—Dexmedetomidine and Propofol—during drug-induced sleep endoscopy in kids with obstructive sleep apnea. It aims to see how each drug affects airway collapse during the procedure and if this relates to persistent OSA after surgery.
What are the potential side effects?
Possible side effects include reactions specific to Dexmedetomidine such as low blood pressure, slow heart rate, dry mouth; and for Propofol: pain at injection site, low blood pressure, fast or slow heart rate.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am eligible for surgery to treat sleep apnea, as confirmed by an ear, nose, and throat doctor.
Select...
I have been diagnosed with sleep apnea based on a sleep study.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am allergic to or cannot take certain anesthesia drugs.
Select...
I cannot have general anesthesia due to health risks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during drug induced sleep endoscopy (dise) procedure, as judged subsequently by video review by the three raters
This trial's timeline: 3 weeks for screening, Varies for treatment, and during drug induced sleep endoscopy (dise) procedure, as judged subsequently by video review by the three raters for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean obstruction score at the tongue base

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Propofol sedationExperimental Treatment1 Intervention
2.5 mg/kg loading dose, then continue at an infusion of 250 mcg/kg/minute.
Group II: Dexmedetomidine sedationExperimental Treatment1 Intervention
1 mcg/kg loading dose, then continue at an infusion of 1 mcg/kg/hour
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexmedetomidine sedation
2015
Completed Phase 3
~110

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,929 Previous Clinical Trials
47,765,137 Total Patients Enrolled
Erin KirkhamLead Sponsor
Erin Kirkham, MD MPHPrincipal InvestigatorUniversity of Michigan

Media Library

Propofol sedation Clinical Trial Eligibility Overview. Trial Name: NCT05303987 — Phase 2
Obstructive Sleep Apnea Research Study Groups: Dexmedetomidine sedation, Propofol sedation
Obstructive Sleep Apnea Clinical Trial 2023: Propofol sedation Highlights & Side Effects. Trial Name: NCT05303987 — Phase 2
Propofol sedation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05303987 — Phase 2
~41 spots leftby Aug 2026